{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:52:56Z","timestamp":1790621576072,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Gastric cancer (GC) is a complex and heterogeneous disease, making it difficult to ascertain the optimal therapeutic approach for individual GC patients. Stromal and immune cell infiltration in GC has a strong correlation with clinical outcomes; however, the underlying mechanisms that drive immunosuppression remain vastly undiscovered. Recent studies validated that anthrax toxin receptor 1 (ANTXR1) is aberrantly expressed in several cancers and holds promise as a new therapeutic target for cancer. However, its immunological roles in GC are still unclear. Here, we show that we identify the distinct stromal and immune cell infiltration in GC between the high and low ANTXR1 expression group by analyzing genomic data. Clinically, ANTXR1 is highly expressed in GC and correlates with adverse clinicopathological characteristics. Additionally, high ANTXR1 expression is linked to markedly poor clinical outcomes and resistance to chemotherapy, whereas the low ANTXR1 expression group is correlated with better outcomes and response to chemotherapy in GC patients. We further revealed the differential landscape of somatic tumor mutation burden (TMB) between the two groups and observed that patients with high ANTXR1 expression suffered from a lower TMB, potentially leading to less sensitivity to checkpoint therapy. Molecularly, results displayed that ANTXR1 is an immunosuppressive element, which may perform its function via promoting the secretion of immunosuppressive factors that play a significant role in modulating tumor-associated fibroblast transformation, M2 macrophage polarization, and T cell exhaustion. Gene set enrichment analysis revealed that cancer-related pathways including epithelial-to-mesenchymal transition, focal adhesion, and transforming growth factor-\u03b2 (TGF-\u03b2) signaling pathways were enriched in high ANTXR1 expression tumors. Our work suggests that ANTXR1 could not only serve as a valuable prognostic biomarker in GC but also be deemed as a potential immunotherapeutic target and useful biomarker of sensitivity to chemotherapy.<\/jats:p>","DOI":"10.3389\/fmolb.2020.598221","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T12:13:57Z","timestamp":1610280837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer"],"prefix":"10.3389","volume":"7","author":[{"given":"Xiaodong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","article-title":"Gastric adenocarcinoma","volume":"3","author":"Ajani","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1378639","DOI":"10.1155\/2019\/1378639","article-title":"The anthrax toxin receptor 1 (ANTXR1) is enriched in pancreatic cancer stem cells derived from primary tumor cultures","volume":"2019","author":"Alcala","year":"2019","journal-title":"Stem Cells Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrgastro.2017.33","article-title":"Molecular subtypes in cancers of the gastrointestinal tract","volume":"14","author":"Bijlsma","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/0008-5472.CAN-16-1911","article-title":"TEM8\/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer","volume":"78","author":"Byrd","year":"2018","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.14326","article-title":"Anthrax toxin receptor 1\/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K\/AKT\/mTOR signaling pathway","volume":"111","author":"Cai","year":"2020","journal-title":"Cancer Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","article-title":"TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types","volume":"21","author":"Chaudhary","year":"2012","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3892\/ijo.29.5.1311","article-title":"Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance","volume":"29","author":"Davies","year":"2006","journal-title":"Int. J. Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"102015","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat. Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00018-019-03398-6","article-title":"TGFbeta-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer","volume":"77","author":"Hua","year":"2020","journal-title":"Cell. Mol. Life Sci"},{"key":"B17","first-page":"2141","article-title":"Epithelial-mesenchymal transition in gastric cancer","volume":"7","author":"Huang","year":"2015","journal-title":"Am. J. Transl. Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"17804","DOI":"10.3748\/wjg.v20.i47.17804","article-title":"Cancer-associated fibroblasts in digestive tumors","volume":"20","author":"Huang","year":"2014","journal-title":"World J. Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","article-title":"Comparative molecular analysis of gastrointestinal adenocarcinomas","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","article-title":"A history of exploring cancer in context","volume":"18","author":"Maman","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/2159-8290.CD-17-1260","article-title":"Targeted therapies for targeted populations: anti-EGFR treatment for EGFR-amplified gastroesophageal adenocarcinoma","volume":"8","author":"Maron","year":"2018","journal-title":"Cancer Discov"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.3748\/wjg.v21.i19.5778","article-title":"Gastric cancer and the epoch of immunotherapy approaches","volume":"21","author":"Niccolai","year":"2015","journal-title":"World J. Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"gkv007","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ejso.2004.07.023","article-title":"Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression","volume":"30","author":"Rmali","year":"2004","journal-title":"Eur. J. Surg. Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"40840","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S1470-2045(18)30512-6","article-title":"Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer","volume":"19","author":"Roviello","year":"2018","journal-title":"Lancet Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/ijms20153736","article-title":"Adapting and surviving: intra and extra-cellular remodeling in drug-resistant gastric cancer cells","volume":"20","author":"Russi","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00262-019-02392-y","article-title":"ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy","volume":"68","author":"Sotoudeh","year":"2019","journal-title":"Cancer Immunol. Immunother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1172\/JCI120481","article-title":"Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release","volume":"128","author":"Szot","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of EMT in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol. Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2013an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","article-title":"Gastric cancer","volume":"388","author":"Van Cutsem","year":"2016","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.598221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T12:14:00Z","timestamp":1610280840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.598221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":38,"alternative-id":["10.3389\/fmolb.2020.598221"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2020.598221","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"article-number":"598221"}}